An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044
Clinical trial NCT02319642 · COMPLETED
Trial details
- NCT number
- NCT02319642
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2016-12-01
- Enrollment
- 347
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.